CEO-linked entity for Longevity Health (NASDAQ: XAGE) buys 689,656 shares in open market

Rhea-AI Filing Summary

Longevity Health Holdings, Inc. director and Chief Executive Officer Ajjarapu J. Ram reported an indirect open-market purchase of 689,656 shares of Common Stock at $0.29 per share. The shares are held through International Capital Partners LLC, and total indirect holdings reported after the transaction are 689,656 shares. A footnote states that the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Insights

Insider transactions analyst

CEO-related entity bought 689,656 XAGE shares in the open market.

The filing shows an indirect open-market purchase of 689,656 Longevity Health Holdings shares at $0.29 each. The trade is attributed to International Capital Partners LLC, an entity associated with CEO and director Ajjarapu J. Ram, rather than a direct personal account.

Post-transaction, the filing reports 689,656 shares held indirectly. A footnote clarifies that the reporting person disclaims beneficial ownership except for his pecuniary interest, which means economic exposure but possible limits on voting or investment control. The net effect is a sizeable net buy, but overall impact depends on the company’s total share count, which is not detailed here.

Insider Trade Summary

Net Buyer: 689,656 shares ($200,000)

Net Buy 1 txn

Insider Ajjarapu J. Ram

Role Chief Executive Officer

Bought 689,656 shs ($200K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	689,656	$0.29	$200K

Holdings After Transaction: Common Stock — 689,656 shares (Indirect, By International Capital Partners LLC)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 689,656 shares Purchase price: $0.29 per share Indirect holdings after transaction: 689,656 shares +1 more

4 metrics

Shares purchased 689,656 shares Open-market purchase on 2026-03-16

Purchase price $0.29 per share Common Stock transaction

Indirect holdings after transaction 689,656 shares Total shares following transaction

Net buy-sell shares 689,656 shares transactionSummary net-buy

Key Terms

open-market purchase, indirect ownership, pecuniary interest, beneficial ownership

4 terms

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"direct_or_indirect: "I" and nature_of_ownership: "By International Capital Partners LLC""

pecuniary interest financial

"disclaims beneficial ownership ... except to the extent of his pecuniary interest"

beneficial ownership financial

"disclaims beneficial ownership of the securities reported herein"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ajjarapu J. Ram

(Last) (First) (Middle)

2403 SIDNEY STREET, SUITE 300

(Street)

PITTSBURGH PENNSYLVANIA 15203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Longevity Health Holdings, Inc. [ XAGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		P		689,656	A	$0.29	689,656	I	By International Capital Partners LLC(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.

	/s/ J. Ram Ajjarapu	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did XAGE report for Ajjarapu J. Ram?

Longevity Health Holdings (XAGE) disclosed that an entity associated with CEO and director Ajjarapu J. Ram bought 689,656 shares of Common Stock. The shares were acquired in an open-market purchase at $0.29 per share, resulting in reported indirect holdings of 689,656 shares.

At what price were the Longevity Health (XAGE) shares purchased in this Form 4?

The Form 4 shows an open-market purchase of XAGE Common Stock at $0.29 per share. A total of 689,656 shares were acquired at this price, indicating a meaningful cash outlay by the associated entity, International Capital Partners LLC.

How many XAGE shares does the CEO-related entity hold after this transaction?

After the reported transaction, the Form 4 lists 689,656 XAGE shares held indirectly. These shares are owned through International Capital Partners LLC, with CEO Ajjarapu J. Ram reporting the position while disclaiming beneficial ownership beyond his pecuniary interest.

Is the XAGE CEO’s purchase direct or through another entity?

The purchase is reported as indirect ownership through International Capital Partners LLC. The filing notes that Ajjarapu J. Ram disclaims beneficial ownership of the securities except to the extent of his pecuniary interest, so the transaction is economically linked but held via the LLC.

Does this XAGE Form 4 represent a net buy or sell by the reporting person?

The Form 4 reflects a net buy position. The transactionSummary shows 689,656 shares purchased and zero shares sold, resulting in net buy-sell shares of 689,656 and a net-buy direction for this filing.